Roth MKM Reinstates Buy on LeMaitre Vascular, Announces $100 Price Target

Benzinga · 05/31 10:01
Roth MKM analyst Jason Wittes reinstates LeMaitre Vascular (NASDAQ:LMAT) with a Buy and announces $100 price target.